2269 Wuxi Biologics (Cayman) Inc. HKEX · China

Wuxi Biologics (Cayman) (2269) news

Wuxi Biologics (Cayman) Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2269, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Wuxi Biologics (Cayman) news

We have not published a story on Wuxi Biologics (Cayman) yet. When there is news, it will appear here.

Questions about Wuxi Biologics (Cayman)

What is the ticker symbol of Wuxi Biologics (Cayman)?

Wuxi Biologics (Cayman) Inc. trades under the ticker 2269 on HKEX.

Where is Wuxi Biologics (Cayman) listed?

Wuxi Biologics (Cayman) Inc. is listed on HKEX. Our directory also records these other listings: GETTEX:1FW2; LS:A2QJCN; LSX:A2QJCN; OTC:WXIBF; OTC:WXXWY; SET:WUXI06; SET:WUXI13.

Which country or territory is Wuxi Biologics (Cayman) listed under?

Our directory records Wuxi Biologics (Cayman) Inc. under China.

What does Wuxi Biologics (Cayman) do?

Our directory classifies Wuxi Biologics (Cayman) Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Wuxi Biologics (Cayman)?

The ISIN recorded for Wuxi Biologics (Cayman) Inc. is KYG970081173.

Does aibio.space cover Wuxi Biologics (Cayman)?

aibio.space lists Wuxi Biologics (Cayman) Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Wuxi Biologics (Cayman)?

Companies in our directory listed in the same country and business area as Wuxi Biologics (Cayman): Beijing Luzhu Biotechnology Co., Boji Medical Technology Co., Beijing Kawin Technology Share-Holding Co., Hebei Changshan Biochemical Pharmaceutical Co., GemPharmatech Co., 3SBio.

Investor discussion: Wuxi Biologics (Cayman)

Members talk about Wuxi Biologics (Cayman) (2269). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Wuxi Biologics (Cayman), newest first. Each line links the filing it comes from.

Jan 14, 2026Mergers
Transaction under the Listing Rules: Joint Announcement. Source
Jan 6, 2025Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION - ASSET TRANSACTION RELATED TO VACCINES IRELAND FACILITY. Source

Press releases

Headlines of Wuxi Biologics (Cayman)'s own announcements, newest first. Each opens the full release on the newswire that carried it.

Aug 25, 2026HKEXnews
INSIDE INFORMATION - 2026 INTERIM RESULTS PRESENTATION
Aug 25, 2026HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026
Jun 10, 2026HKEXnews
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 10, 2026
Jun 9, 2026HKEXnews
GRANT OF RESTRICTED SHARES UNDER RESTRICTED SHARE AWARD SCHEME
May 31, 2026HKEXnews
INSIDE INFORMATION - PRESENTATION AT 2026 BUSINESS UPDATE MEETING
May 26, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT - PROPOSED ON-MARKET SHARE REPURCHASE
May 19, 2026HKEXnews
NOTICE OF ANNUAL GENERAL MEETING
Mar 24, 2026HKEXnews
INSIDE INFORMATION - 2025 ANNUAL RESULTS PRESENTATION
Mar 24, 2026HKEXnews
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025
Feb 10, 2026HKEXnews
POSITIVE PROFIT ALERT
Jan 15, 2026HKEXnews
INSIDE INFORMATION - PLACING OF EXISTING SHARES BY SUBSTANTIAL SHAREHOLDER
Jan 14, 2026HKEXnews
Joint Announcement
Jan 11, 2026HKEXnews
INSIDE INFORMATION - PRESENTATION AT 2026 ANNUAL HEALTHCARE CONFERENCE
Sep 2, 2025HKEXnews
CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE PAYLOAD-LINKERS MASTER SERVICES AGREEMENTS
Aug 19, 2025HKEXnews
INSIDE INFORMATION - 2025 INTERIM RESULTS PRESENTATION
Aug 19, 2025HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
Jun 15, 2025HKEXnews
INSIDE INFORMATION - PLACING OF EXISTING SHARES BY SUBSTANTIAL SHAREHOLDER
Jun 6, 2025HKEXnews
(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 6, 2025; (2) CHANGE OF DIRECTOR; AND (3) CHANGE IN COMPOSITION OF BOARD COMMITTEES
Mar 26, 2025HKEXnews
GRANT OF RESTRICTED SHARES UNDER RESTRICTED SHARE AWARD SCHEME
Mar 25, 2025HKEXnews
INSIDE INFORMATION - 2024 ANNUAL RESULTS PRESENTATION

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2269 on TradingView.

Listing details

Company: Wuxi Biologics (Cayman) Inc.
Ticker: 2269
Listing: HKEX
Country or territory: China
Business scope: Biotechnology
ISIN: KYG970081173
Other listed symbols: GETTEX:1FW2; LS:A2QJCN; LSX:A2QJCN; OTC:WXIBF; OTC:WXXWY; SET:WUXI06; SET:WUXI13
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction